Nilotinib Linked to Metabolic Syndrome and CVD in CML Nilotinib Linked to Metabolic Syndrome and CVD in CML
Investigators suggest using other TKIs in patients with preexisting diabetes and hyperlipidemia.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Diabetes | Drugs & Pharmacology | Endocrinology | Hematology | Metabolic Syndrome | Nilotinib | Tasigna